205 related articles for article (PubMed ID: 11516104)
1. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system.
Koistinen P; Siitonen T; Mäntymaa P; Säily M; Kinnula V; Savolainen ER; Soini Y
Leukemia; 2001 Sep; 15(9):1433-41. PubMed ID: 11516104
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway.
Shen BQ; Lee DY; Zioncheck TF
J Biol Chem; 1999 Nov; 274(46):33057-63. PubMed ID: 10551875
[TBL] [Abstract][Full Text] [Related]
3. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS).
Tanimoto T; Jin ZG; Berk BC
J Biol Chem; 2002 Nov; 277(45):42997-3001. PubMed ID: 12226078
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.
Gerber HP; McMurtrey A; Kowalski J; Yan M; Keyt BA; Dixit V; Ferrara N
J Biol Chem; 1998 Nov; 273(46):30336-43. PubMed ID: 9804796
[TBL] [Abstract][Full Text] [Related]
5. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells.
Feng Y; Venema VJ; Venema RC; Tsai N; Caldwell RB
Biochem Biophys Res Commun; 1999 Mar; 256(1):192-7. PubMed ID: 10066445
[TBL] [Abstract][Full Text] [Related]
6. VEGF-induced permeability increase is mediated by caveolae.
Feng Y; Venema VJ; Venema RC; Tsai N; Behzadian MA; Caldwell RB
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439
[TBL] [Abstract][Full Text] [Related]
7. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR).
Kroll J; Waltenberger J
Biochem Biophys Res Commun; 1998 Nov; 252(3):743-6. PubMed ID: 9837777
[TBL] [Abstract][Full Text] [Related]
8. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.
Kroll J; Waltenberger J
Biochem Biophys Res Commun; 1999 Nov; 265(3):636-9. PubMed ID: 10600473
[TBL] [Abstract][Full Text] [Related]
9. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth.
Ratajczak MZ; Ratajczak J; Machalinski B; Majka M; Marlicz W; Carter A; Pietrzkowski Z; Gewirtz AM
Br J Haematol; 1998 Dec; 103(4):969-79. PubMed ID: 9886308
[TBL] [Abstract][Full Text] [Related]
10. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system.
Ogunshola OO; Antic A; Donoghue MJ; Fan SY; Kim H; Stewart WB; Madri JA; Ment LR
J Biol Chem; 2002 Mar; 277(13):11410-5. PubMed ID: 11777931
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src.
He H; Venema VJ; Gu X; Venema RC; Marrero MB; Caldwell RB
J Biol Chem; 1999 Aug; 274(35):25130-5. PubMed ID: 10455194
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
[TBL] [Abstract][Full Text] [Related]
13. The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling.
Thakker GD; Hajjar DP; Muller WA; Rosengart TK
J Biol Chem; 1999 Apr; 274(15):10002-7. PubMed ID: 10187776
[TBL] [Abstract][Full Text] [Related]
14. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.
Shen BQ; Lee DY; Gerber HP; Keyt BA; Ferrara N; Zioncheck TF
J Biol Chem; 1998 Nov; 273(45):29979-85. PubMed ID: 9792718
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.
Fiedler W; Graeven U; Ergün S; Verago S; Kilic N; Stockschläder M; Hossfeld DK
Blood; 1997 Mar; 89(6):1870-5. PubMed ID: 9058706
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
[TBL] [Abstract][Full Text] [Related]
17. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathways.
Igarashi J; Michel T
J Biol Chem; 2001 Sep; 276(39):36281-8. PubMed ID: 11470796
[TBL] [Abstract][Full Text] [Related]
19. Expression and regulation of endothelial nitric oxide synthase by vascular endothelial growth factor in ECV 304 cells.
Park JS; Hong GR; Baek SW; Shin DG; Kim YJ; Shim BS
J Korean Med Sci; 2002 Apr; 17(2):161-7. PubMed ID: 11961297
[TBL] [Abstract][Full Text] [Related]
20. VEGF receptor signaling and endothelial function.
Kliche S; Waltenberger J
IUBMB Life; 2001 Jul; 52(1-2):61-6. PubMed ID: 11795595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
